140 related articles for article (PubMed ID: 29932858)
1. Not All Ductal Carcinomas In Situ Are Created IDLE (Indolent Lesions of Epithelial Origin).
Alexander M; Beyda J; Nayak A; Jaffer S
Arch Pathol Lab Med; 2019 Jan; 143(1):99-104. PubMed ID: 29932858
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Follow-up of Breast DCIS Diagnosed on Biopsies: A Single Institutional Study of 575 Patients.
Yan M; Bomeisl P; Gilmore H; Harbhajanka A
Int J Surg Pathol; 2021 Dec; 29(8):836-843. PubMed ID: 33890815
[TBL] [Abstract][Full Text] [Related]
4. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
5. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Mittendorf EA; Arciero CA; Gutchell V; Hooke J; Shriver CD
Curr Surg; 2005; 62(2):253-7. PubMed ID: 15796952
[TBL] [Abstract][Full Text] [Related]
6. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS; Park S; Cho J; Park JM; Kim SI; Park BW
J Surg Oncol; 2013 Mar; 107(4):388-92. PubMed ID: 23007901
[TBL] [Abstract][Full Text] [Related]
7. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
8. [Ductal carcinoma in situ (DCIS) and biopsy of the sentinel lymph node].
Chvalný P; Donát R; Dyttert D; Siska D; Sabol M; Králik R; Mracna P; Malina J; Veselý J; Duchaj B; Cích D; Lehotská V; Rauová K; Smreková M; Galbavý S; Macák D; Macháleková K; Bokes T
Rozhl Chir; 2011 Jun; 90(6):352-60. PubMed ID: 22026103
[TBL] [Abstract][Full Text] [Related]
9. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ.
King TA; Farr GH; Cederbom GJ; Smetherman DH; Bolton JS; Stolier AJ; Fuhrman GM
Am Surg; 2001 Sep; 67(9):907-12. PubMed ID: 11565774
[TBL] [Abstract][Full Text] [Related]
10. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract][Full Text] [Related]
11. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
[TBL] [Abstract][Full Text] [Related]
12. The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study.
Tunon-de-Lara C; Chauvet MP; Baranzelli MC; Baron M; Piquenot J; Le-Bouédec G; Penault-Llorca F; Garbay JR; Blanchot J; Mollard J; Maisongrosse V; Mathoulin-Pélissier S; MacGrogan G
Ann Surg Oncol; 2015 Nov; 22(12):3853-60. PubMed ID: 25777085
[TBL] [Abstract][Full Text] [Related]
13. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
Tsang WY; Chan JK
Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
[TBL] [Abstract][Full Text] [Related]
14. Underestimation of invasive lesions in patients with ductal carcinoma in situ of the breast diagnosed by ultrasound-guided biopsy: a comparison between patients with and without HER2/neu overexpression.
Chang WC; Hsu HH; Yu JC; Ko KH; Peng YJ; Tung HJ; Chang TH; Hsu GC
Eur J Radiol; 2014 Jun; 83(6):935-941. PubMed ID: 24666513
[TBL] [Abstract][Full Text] [Related]
15. High EZH2 expression in ductal carcinoma in situ diagnosed on breast core needle biopsy is an independent predictive factor for upgrade on surgical excision.
Genco IS; Ozgultekin B; Hosseini H; Hackman K; Ferreira L; Santagada E; Wahl S; Hajiyeva S
Pathol Res Pract; 2020 Dec; 216(12):153283. PubMed ID: 33197837
[TBL] [Abstract][Full Text] [Related]
16. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Chin-Lenn L; Mack LA; Temple W; Cherniak W; Quinn RR; Ravani P; Lewin AM; Quan ML
Ann Surg Oncol; 2014 Jan; 21(1):66-73. PubMed ID: 24046105
[TBL] [Abstract][Full Text] [Related]
20. Tumor thickness and histological features as predictors of invasive foci within preoperatively diagnosed ductal carcinoma in situ.
Mori K; Takeda M; Kodama Y; Kiyokawa H; Yasojima H; Mizutani M; Otani Y; Morikawa N; Masuda N; Mano M
Hum Pathol; 2017 Jun; 64():145-155. PubMed ID: 28434924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
